Healthcare / Health Information ServicesOslo
$1.85
-0.17 (-8.42%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 23%
FCF escenarios
weak_data · normalized FCF $-7.3M · quality 67.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
21/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$58M
P/E
N/A
•EV/EBITDA
8.1x
↓ROE
-17.4%
↓Gross Margin
92.9%
↑Debt/Equity
0.09
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-8.7%
FCF CAGR
—
FCF margin
-22.3%
FCF / Net income
0.46x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $14.8M · net income $-7.1M · FCF $-3.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $14.8M | $14.8M | $18.0M | $21.0M | $19.4M |
| Net Income | $-7.1M | $-7.1M | $-20.6M | $-5.0M | $-10.3M |
| EBITDA | $7.3M | $7.3M | $-4.0M | $8.1M | $7.2M |
| EPS | -0.23 | -0.23 | -0.86 | -0.26 | -0.58 |
| Gross Margin | 92.9% | 92.9% | 82.1% | 95.0% | 97.3% |
| Operating Margin | -36.1% | -36.1% | -72.1% | -14.4% | -32.7% |
| Net Margin | -48.1% | -48.1% | -114.7% | -23.7% | -52.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.09 | 0.09 | 0.16 | 0.22 | 0.16 |
| Current Ratio | 0.94 | 0.94 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-3.3M | $-3.3M | $-12.0M | $-7.3M | $-25.7M |
| Returns | |||||
| ROE | -17.4% | -17.4% | -77.8% | -21.9% | -34.8% |
| Valuation | |||||
| EV/EBITDA | 8.10 | 8.10 | — | 12.56 | 15.71 |
| P/B | 1.42 | 1.42 | 1.99 | 4.30 | 3.76 |
| Growth & Yield | |||||
| Revenue Growth | -17.7% | -17.7% | -14.6% | 8.3% | — |
| EPS Growth | 73.6% | 73.6% | -230.4% | 55.2% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-48.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.86 → -0.23
Residual
-48.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.